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Renal function and biopsy findings in patients on long-term lithiuni
treatment. Nine patients on long-term lithium treatment (3 to 13 years)
had abnormal renal function with a decreased GFR and/or a decreased
maximal urinary concentration capacity. Four patients had received
lithium as the only drug, whereas five patients had had concomitanL
treatment with neuroleptics. No patient had a history of nephrourologi-
cal diseases. Abnormal renal morphology was present in the biopsy
samples from all patients. Cortical fibrosis was found in a variable
degree. Dilated tubules and microcysts in which the epithelial lining was
clearly abnormal were found in the majority of samples. Electron
micrographically, two types of abnormal epithelial cells were observed,
one with small elongated mitochondria with dense matrix and the other
with larger spherical and less dense mitochondria. In distal tubules,
mitochondrial swelling, accumulation of cytosegrosomes, and nuclear
pyknosis dominated the picture. These findings indicate a tubulointer.
stitial nephropathy and support the hypothesis that long-term lithium
treatment may cause renal damage in susceptible patients.
Fonction rénale et constatations biopsiques chez les malades soumis it
un traitement au long cours par le lithium. Neuf malades soumis a un
traitement au long cours par Ic lithium ant une modification de
fonctionnement renal sous Ia forme d'une diminution du debit de
filtration glomerulaire ct/au de Ia capacitC de concentration. Ces
malades sont traités par Ic lithium depuis 3 a 13 ans. Quatre malades oni
recu dii lithium seulement alors que les 5 autres avaient en mCme temps
des neuroleptiques. Aucun d'entre eux n'a d'antécCdent néphro-urolo-•
gique. La morphologie rénale est anormale chez tous les malades. Des
lesions de fibrose corticale dintensité variable sont observées. Des
dilatations tubulaires et des formations kystiques dont l'epithéliurn
limitant est nettement anormal sont constatées dans Ia majoritC des cas.
En microscopic électronique deux types de cellules epithéliales anor-
males sont observes, l'un avec des mitochondnies petites et allongees.
avec une matrice dense. l'autre avec des mitochondnies plus grandes.
spheriques et moms denses. Dans les tubes distaux le gonflement
mitochondrial, l'accumulation de cytosegrosomes ci Ia pycnose nu-
cléaire dominent. Ces constatations traduisent une nephropathie tu-
bulo-interstitielle et sont en faveur de l'hypothèsc scion laquelle le
traitement au long cours par Ic lithium peut determiner des lesions
rénales chez certains malades.
Lithium treatment has been used for many years in affective
disorders, and during the last 10 years prophylactic treatment
has gained widespread acceptance. Lithium treatment is un-
doubtedly a very valuable tool for controlling affective disor-
ders [1]. A recent report [2] of renal damage caused by long-
term lithium treatment has therefore caused great concern, and
large-scale screening of the renal function of patients on lithium
treatment has since been carried out [3—7, 23]. In some studies,
a high incidence of abnormal renal function tests has been
observed, for example, decreased maximal urinary concentra-
tion capacity and GFR. Only a few reports have dealt with the
morphologic changes in kidney biopsies. Bucht et al [8] ob-
served only slight changes in nine patients treated with lithium
alone, but signs of interstitial fibrosis were more marked in five
patients in combination therapy with lithium and neuroleptics.
Hansen et al [31 studied 14 patients and classified the renal
lesions as a chronic interstitial nephropathy with increased
amounts of fibrotic tissue, both in the medulla and in the cortex.
Cystic formation was found in 40% of the patients. These
findings were similar to those previously described by the same
group [2]. Two case reports [9, 10] and preliminary reports by
Kincaid-Smith et a! [11, 12] also indicate that lithium may cause
renal lesions, but little information on the presence or extent of
impairment of renal function was given. During our screening of
lithium patients in Goteborg, Sweden, a number of patients
were found to have decreased renal function. Renal biopsy was
performed in nine patients, and the findings are reported as
follows:
Methods
Patient screening. Screening for renal disease in patients on
long-term lithium treatment included a clinical examination and
renal function tests. More than 300 patients were investigated,
and a number of patients with signs of decreased renal function
were found [23]. Nine patients were subjected to renal biopsy
for diagnostic purposes. Details of these patients are given in
Table 1. There were six men and three women, and their ages
ranged from 36 to 64 years. Table I lists the psychiatric
diagnoses: Seven patients had bipolar manodepressive psycho-
sis, one patient had paranoid psychosis, and one had manic
psychosis. The case reports were scrutinized for somatic ill-
nesses, especially for signs and symptoms of nephrourological
disease. No such findings were recorded. All the patients had
been exposed to lithium for a considerable period of time, in
seven patients for more than 7 years. The types of lithium
tablets taken and the duration of treatment are also indicated in
Table 1. Seven patients were on sustained-release tablets at the
time of investigation, and seven patients had previously taken
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Psychiatric
diagnosis
Bipolar
manodepressive
psychosis
2 M 48 Bipolar
manodepressive
psychosis
3 F 47 Bipolar
manodepressive
psychosis
4 F 36 Bipolar
manodepressive
psychosis
5 M 38 Bipolar
manodepressive
psychosis
6 M 66 Bipolar
manodepressive
psychosis
7 M 46 Paranoid
psychosis
8 M 39 Manic
psychosis
9 F 64 Bipolar
manodepressive
psychosis
Somatic diseases years years Other drugs
4 SR 4 Levaxin
10 SRI
RD 7
SR 2
13 RDS
SR 8
10 RD 10 Neuroleptics
7 RD 5 Neuroleptics
SR 2
10 RD 9 Neuroleptics
SR 1
7 SR 4 Neuroleptics
RD 3
8 SR8
3 RD 2 Levaxin®
SR I
Significant
Highest serum adverse
lithium value lithium
mmoleslliter effects
Abbreviations used are SR, sustained release; RD, rapidly disintegrating; M, male; F, female.
Table 2. Blood pressure, renal function, and biopsy findings in nine patients on long-term lithium treatment
a Severe damage prohibited proper evaluation.
Biopsy findings (cortical tissue)
rapidly disintegrating tablets. Two patients had taken sustained-
release tablets, and one patient, rapidly disintegrating tablets
throughout the period of treatment. Other drugs taken, such as
neuroleptics, were also recorded. Five patients had received
concomitant medication with neuroleptics. The highest serum
lithium concentrations recorded were also noted; only two
patients had had concentrations higher than 1.6 mmoles/liter
and another two patients had had concentrations between 1.2
and 1.6 mmoles/liter. The remaining patients had never had
concentrations higher than 1 .2 mmoles/liter. Table 1 also indi-
cates whether severe adverse effects were recorded: 6 patients
had had symptomatic polyuria, whereas the remainder had had
no troublesome adverse effects, although three patients were on
Levaxin® (levotyroxine) treatment.
At the start of treatment, the serum creatinine concentrations
had been normal, and there had been no evidence of renal
disease in any case. All patients had been monitored four to six
times a year, with the aim of controlling the lithium concentra-
tion between 0.6 and 1.2 mmoles/Iiter (12 hours after the last
dose). In some patients higher values had occasionally been
recorded, as noted in Table I.
Some clinical data are given in Table 2. Admission blood
pressure was sometimes increased, but only one patient (patient
1) was on treatment for hypertension. GFR was reduced in
664
no, Sex yr
1 M 55
Patient Age
A are/I et 0/
Table I. Clinical data for nine patients on long-term lithium treatmenta
Duration of
lithium treatment
Total Drug
Neuroleptics
Levaxin®
Hypothyroidism
Epilepsy
Goitre
0
0
Gastric
ulcer
0
0
Hypothyroidism
>1.6
>1.6 Polyuria
<1.2 Polyuria
1.2 to 1.6 Polyuria
1.2 to 1.6
<1.2 Polyuria
<1.2
<1.2 Polyuria
<1.2 Polyuria
Patient
no.
Admission
BP
mm Hg
GFR
mI/mm
Max. urine
cone. m0sm/
kg 1120
—
Sclerosed
glomeruli
no. per total
22/60
Fibrosis
%
51.6
Dilated
tubules
%
10.0 +1 180/120 13
2 130/75 45 258 26/39 66.0 10.0 +
3 130/80 50 256 14/30 16.0 6.8 ++
4 125/90 64 392 1/25 8.0 4.4 +
5 145/100 72 354 2/29 12.4 4.8
6 150/90 63 511 6/20 13.6 3.2
7 165/95 91 776 1/60 1.6 4.4 +
8 140/70 109 737 1/20 0 1.0
9 165/105 108 666 1/40 0 2.0 0
Epithelial
polymorphisma
Tubular Prox. Dist.
microcysts tubule tubule
+ +
+ +
0
+
+ +
+
+
+
+
+
++ +
+ ++
+ +
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Fig. 1. Renal Cortex with interstitial fihrosLs (patient 1). Irregular
epithelium is noted in dilated tubules. Part of glomerulus with slight
mesangial thickening is shown in left-hand corner. (Epon embedding.
Toluidine blue, x440).
Fig. 2. Renal cortex with three tubular microcysts. the largest measur-
ing 166 s in diameter (patient 7). Epithelial lining irregular. Strongly
PAS positive material in cyst lumen. (Paraffin section, PAS according
to McManus, x 150).
patients I to 6 (Table 2). These patients also had decreased
maximal urinary concentration capacity. Patients 7 to 9 had
normal GFR's, but they did not reach the value of 800 mOsm/kg
H20, used as the normal cut-off limit for urinary concentration
capacity in this study.
Laboratoty methodology. The glomerular filtration rate
(GFR) was measured by the single-injection technique ot
BrØchner-Mortensen [13] with 51Cr-EDTA as the filtration
marker. All values were corrected to 1.73 m2 BSA, and the
reference values used were those given by Granerus and Aurell
114]. The maximal urinary concentration test was performed
according to the method of Delin, Aurell, and Ewald [151, and
the vasopressin test was performed according to deWardener
116]. In each patient, the maximal concentration capacity was
tested at least twice, and the highest urinary osmolality is given.
The lower normal limit was 800 mOsm/kg H20.
Histologic methodology. Tissue specimens from percutane-
ous renal biopsy samples were prepared for light and transmis-
sion electron microscopy according to standard methods. In
four samples, material for direct immunofluorescence was
obtained and immediately frozen and processed for the demon-
stration of IgG, 1gM, lgA, C3, C4, properdin, and fibrinogen
with fluorescein isothiocyanate-conjugated antisera (DAKO,
Denmark) on cryostat microtome sections. Paraffin-embedded
tissue was serially sectioned and stained with hematoxylin-
v.Gieson, hematoxylin-eosin, PAS according to McManus,
Ladewig's variant of Mallory's stain for fibrin, and silver
methenamine according to Jones. Epon-embedded tissue was
sectioned with glass knives on an LKB ultratome III, doubly
contrasted on the grids with U and Pb salts and studied at 60 kV
in a Philips EM 200. Quantitative determinations of the light
microscopical observations were performed at a magnification
of x 157 with a Zeiss integrating ocular I, having a circular area
with a 25-point reticule, corresponding to 0.38 mm2. The two-
dimensional proportions of the different normal and pathologic
tissue components in 10 consecutive fields, corresponding to a
distance of 7 mm, were thus recorded in one section from each
biopsy sample. In this way, the relative amount of renal cortex
occupied by pathologic fibrous tissue and dilated tubules was
recorded. The total number of renal corpuscles and the number
of sclerotic glomeruli were counted in each biopsy. The pres-
ence of severe tubular dilatation, denoted 'microcysts," was
separately recorded and arbitrarily indicated as follows: 0 =
absence of feature, + = presence, ++ = many cysts present in
every section. In the same way, the presence of abnormally
large epithelial cell nuclei was recorded as "epithelial polyrnor-
phism" located in the proximal and distal parts of the nephron,
respectively. In one patient (no. I), the biopsy specimen was
too severely damaged to permit this registration.
Results
The main findings are given in Table 2. The clinical findings
showed the presence of substantial kidney damage in patients I
to 6, with decreased GFR and decreased maximal urinary
concentration capacity. Patients 7 to 9 had reduced concentra-
tion capacity, but their GFR was within normal limits. Com-
pared with the data of Table I, there was no obvious correlation
between the presence of severe renal damage and the duration
of treatment, type of tablet, other concomitant medication,
highest registered serum concentration, or adverse effects, such
as polyuria.
Light microscopy. The main morphologic findings are pre-
sented in Table 2 and Figs. 1—3. Apart from the occurrence of
occasional completely sclerosed renal corpuscles located in
areas of cortical scarring, only minor glomerular changes were
present. Thus, in the majority of the glomeruli, there was a
slight irregular segmental increase in mesangial tissue without
simultaneous hypercellularity. No light microscopically obvi-
ous glomerular basement membrane abnormalities were found.
Within fibrosed areas, the cortex often contained small groups
of lyniphoid cells. In patient I, the morphologic changes were
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Fig. 3. Renal Cortex demonstrating occasional cells with large nuclei: a proximal tubule (patient 7) b distal tubule (patient 6). (H&E, x 370).
extensive, with atrophic tubules confined within focal scarring
occupying more than 50% of the section area and in alternating
areas with dilated profiles of tubules with irregular abnormal
epithelial cells. Slight focal arteriolar hyalinosis was also pres-
ent in the biopsy sample from this patient, but the arterioles
were otherwise normal. No arterial changes were found in the
biopsy samples from the other patients. A general comparison
of medullary tissue changes is not possible in this material
because only four of the nine biopsy samples contained such
tissue. But, all of these four samples showed obvious nuclear
polymorphism, cytoplasmic vacuolization, and variable epithe-
hal cell size in the collecting tubules, and, in three of these
biopsies, a diffuse increase in interstitial fibrous tissue. Dilated
tubules were present in all patients, but to a varying extent. The
most severely damaged kidneys showed a high percentage of
dilated proximal and distal tubules. In all but two biopsy
samples, there were also microcysts, but in which segment of
the nephron these microcysts originated could not be ascer-
tained. Only patient 9 lacked both cortical fibrosis and micro-
cysts. The light microscopic findings were uniform in all nine
biopsies in that nuclear polymorphism (abnormally large and
hyperchromatic nuclei in the epithelial tubular cells in the renal
cortex) was present. This nuclear polymorphism was of varying
degree and extent but was observed in both proximal and distal
tubules (Fig. 3, a and b).
Electron microscopy. Cortical tissue from patients 1, 5, 8,
and 9 was studied electron microscopically. The material
included one or two glomeruli with patent capillaries from each
biopsy sample. The light microscopic observation of only minor
glomerular changes was confirmed at the ultrastructural level.
There were no glomerular basement membrane deposits and no
significant endothelial, mesangial, or epithelial cell changes in
the glomeruli (Fig. 4). Because of the focal nature of the tubular
and interstitial changes and the small amount of biopsy material
available, valid comparisons between individual biopsy samples
were difficult to perform. But in three of the four samples
prominent changes in the tubular epithelium were found. Within
dilated tubules, the epithelial cells demonstrated a marked
increase in the number of mitochondria. Two types of cells
could be identified according to the variable morphology of the
mitochondria. Most numerous were cells with small elongated
mitochondria having a very dense matrix, and less numerous
were cells with larger, spherical, and less dense mitochondria
(Fig. 4). Both types of cells showed slightly irregular nuclear
profiles and small villi on the apical cell surface. The broadened
and often edematous interstitium contained increased amounts
of collagen fibrils, and irregular profiles of fibroblasts were a
frequent finding. In one specimen only, a microcyst could be
identified. The lining cells were flat and uniform in structure
with large multicompartmental vacuoles and dilated cisterns of
endoplasmic reticulum in the cytoplasm. Mitochrondria and
other cell organdIes were not numerous, apical vilhi were
generally lacking, and the nuclei were small and irregular (Fig.
5). The basement membrane of this microcyst was of variable
thickness and density. In which part of the nephron this tubular
cyst was located could not be ascertained from the character of
Yr. • ¾.VA
LU
¶.t' :
,
' Cr4
:::.. ?c'
10pm
Biopsy findings in long-term lithium treatment 667
Fig. 4. Electron micrograph from area depicted in Fig. I (patient I). Renal cortex is shown close to glomerulus (GLOM), with broadened
interstitium (IN) containing profiles of fibroblasts and collagen fibres. Note small capillary (C) close to dilated tubule (LU) bordered by abnormal
epithelial cells. Also note numerous mitochondria of variable density and small number of short villi on luminal surface. Tubular basement
membrane is undulated. (Original magnification, x2500).
the epithelium. In the distal tubules, mitochondrial swelling and
accumulation of cytosegrosomes was a frequent finding. In
occasional cells, nuclear pyknosis as a sign of severe injury
could be demonstrated (Fig. 6).
lm,nunofluorescence. Patients I and 3 to 6 were studied.
There was no significant inimunofluorescent deposition in their
biopsy samples stained for IgG. IgA, 1gM, complement C3, C4,
properdin, or fibrinogen.
Discussion
Only a few studies have been published that present data on
renal biopsy samples from patients on long-term lithium treat-
ment. The question of renal damage in patients on long-term
lithium treatment was first raised by Hestbech et al [21 in a
study of 14 patients admitted to the hospital because of lithium
intoxication. As lithium is a nephrotoxic drug, its acute effects
are well known, but Hestbech et a! also described chronic
changes in these biopsy samples. Therefore, the fear Ihat
prophylactic lithium treatment in affective disorders may entail
a considerable risk of chronic renal damage became wide-
spread. Large-scale studies of patients have shown, however,
that although many patients have abnormal renal function, signs
of severe renal damage are quite rare [3—7]. The nephrotoxicity
of long-term lithium treatment has therefore been questioned
[17—18].
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Fig. 5. Electron micrograph (patient I) showing epithelia! cells in tubular microcysts (LU). Note large inclusions (vac), dilated cisterns of
endoplasmic reticulum, and presence of small mitochondria (mit). Basement membrane (BM) is irregular and of variable thickness. Arrowhead
indicates tight junction at luminal surface. (Original magnification, >< 11000).
We have now compiled data on nine more patients who have
been on lithium treatment for considerable periods of time. Otir
patients lacked a history of nephrourologic diseases, and they
had not had any urinary tract infection as far as they could
remember and the records showed.
Four of these nine patients had received lithium as monother-
apy. In these patients, we observed considerable morphologic
changes in the renal biopsies—cortical scarring, dilated tubules,
and microcysts. Pronounced epithelial polymorphism has also
been documented, These changes are very similar to those
reported by Hestbech et al [2] and Hansen ci al [3]. Therefore,
patients on long-term lithium treatment with abnormal renal
function have a uniform renal pathology that indicates tubuloin-
terstitial nephropathy, characterized by epithelial damage with
cystic tubular atrophy and interstitial scarring. This finding
strengthens the hypothesis that the renal damage is caused by
the long-term lithium treatment, as suggested by several large
clinical surveys [3—5, 7].
In certain reports the incidence of abnormal renal function
has been very high, for example, 50% concentration defects [71
and 20% decreased GFR [5]. In the larger reports, it has been
established that the renal damage is correlated to the duration of
treatment, dosage, and the mode of administration of the
lithium, for example, sustained release or rapidly disintegrating
tablets [7, 20, 23].
Very few patients, however, have had severely impaired
renal function. One of our patients (no. 1) suddenly deteriorated
after several years of lithium treatment. A brief description of
this case has been given elsewhere [19]. This man had no signs
of renal damage at the start of the treatment and had received
lithium as monotherapy. He was well controlled with serum
lithium analysis every 2 months, and all values were within
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Fig. 6. Electron micrograph (patient 5) showing inner strip of outer zone of medulla. Profile of pars recta of distal tubule (DT) with abnormal
epithelium is shown. Note the numerous cytosegrosomes with variable density in the majority of the cells and the varying nuclear chromatin
structure with prominent irregular nucleoli, Note mitochondrial swelling and nuclear pyknosis in two injured adjacent cells (arrows). (Original
magnification, x 3000).
normal limits except on one occasion, when the value was 2.2
mmoles/liter, but was rapidly corrected. Nevertheless, he de-
veloped progressive renal damage (GFR. 13 mI/mm; serum
creatinine, 500 lJ.moles/liter). Interestingly, the progression
stopped completely after withdrawal of lithium therapy. He
even regained some function and is now, 3 years later, in a
stable clinical condition with a GFR of 25 mI/mm. During this
period of time, there have been no further signs of renal disease.
A contributory factor in the development of renal damage in
this patient may have been the institution of a very active
rehabilitation program when the patient did not feel well. This
program included heavy exercise in a hot climate with sauna
baths several times a week. This may have caused frequent
episodes of high lithium concentrations, which were not discov-
ered at the regular controls. It has been pointed out that
meticulous avoidance of dehydrating procedures will reduce the
risks of lithium treatment [41.
This study adds data on the morphologic findings in lithium-
induced renal damage. The lesions are unspecific, indicating
tubular and interstitial nephropathy. Experimental studies in
rats and dogs have demonstrated the acute effect of lithium
administration. Initially, severe lesions of the mitochondria and
endoplasmic reticulum and later progression to frank necrosis
of the tubular epithelial cells have been documented [211. The
damaged portions are mainly the distal convoluted tubule and
the collecting ducts. At higher dosage concentrations, the
670 Aurell er a!
whole nephron is damaged [21, 22]. Short-term experimental
results cannot be compared easily with long-term effects in
man, but the distribution of lesions within the nephron is
similar. The electron microscopic observations in this biopsy
material indicate that severe structural derangement of cyto-
plasmic organelles of the tubular epithelium also occurs during
chronic lithium treatment. Although the morphologic evidence
is circumstantial, the accumulated clinical and histopathologic
observations indicate that long-term lithium treatment may
indeed cause renal damage in susceptible patients.
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